Ye Lu

Anlotinib Inhibits PFKFB3-Driven Glycolysis in Myofibroblasts to Reverse Pulmonary Fibrosis

S. Cai, H. Dong, Xiaojing Meng, 2021, Frontiers in Pharmacology.

Extracellular HSP90α Interacts With ER Stress to Promote Fibroblasts Activation Through PI3K/AKT Pathway in Pulmonary Fibrosis

Wei Li, S. Cai, H. Dong, 2021, Frontiers in Pharmacology.

Extracellular HSP90α promotes cellular senescence by modulating TGF‐β signaling in pulmonary fibrosis

Wei Li, Hai-Jin Zhao, S. Cai, 2022, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Anti-PD-L1 antibody alleviates pulmonary fibrosis by inducing autophagy via inhibition of the PI3K/Akt/mTOR pathway.

S. Cai, H. Dong, Xiaojing Meng, 2022, International immunopharmacology.

HDM induce airway epithelial cell ferroptosis and promote inflammation by activating ferritinophagy in asthma

Hai-Jin Zhao, S. Cai, H. Dong, 2022, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Pemafibrate attenuates pulmonary fibrosis by inhibiting myofibroblast differentiation.

Yao Deng, Shuyu Chen, Shengming Liu, 2022, International immunopharmacology.

Tetrandrine Modulates Rheb-mTOR Signaling-Mediated Selective Autophagy and Protects Pulmonary Fibrosis

S. Cai, H. Dong, Weimou Chen, 2021, Frontiers in Pharmacology.

Pemafibrate attenuates pulmonary fibrosis by inhibiting myofibroblast differentiation.

Yao Deng, Shuyu Chen, Shengming Liu, 2022, International immunopharmacology.